Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-15-014932
Filing Date
2015-11-16
Accepted
2015-11-16 17:01:01
Documents
2
Period of Report
2015-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1654
2 NOVA T POA novatpoa.txt EX-24.POA 3476
  Complete submission text file 0001179110-15-014932.txt   6783
Mailing Address C/O ARENA PHARMACEUTICALS, INC. 6166 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Nova Tina Susan (Reporting) CIK: 0001302605 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36156 | Film No.: 151236001

Mailing Address 7000 SHORELINE COURT, SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 250 SOUTH SAN FRANCISCO CA 94080 (650) 243-6300
VERACYTE, INC. (Issuer) CIK: 0001384101 (see all company filings)

EIN.: 205455398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8071 Services-Medical Laboratories